Skip to main content

FDA: PCNS Drugs Advisory Committee Results for Avid's Amyvid Alzheimer's Amyloid Neuroimaging Agent

A fuller report from The New York Times:

F.D.A. Sees Promise in Alzheimer’s Imaging Drug
By GINA KOLATA
The New York Times
Published: January 20, 2011

"A committee voted that the agency should approve the first test that can show the characteristic plaques of Alzheimer’s disease in the brain of a living person."

Read the full article

Comments

Popular posts from this blog

Welcome to Fall Semester!

Welcome to Summer Session!

Summer Session begins next week for me. I am teaching several courses that I much enjoy: Introduction to Clinical Neuropsychology, Psychopharmacology, Cognitive, and Clinical Neuroscience. Let the sun shine and the coffee flow!